Human Immunodeficiency Virus (HIV) 2 Superinfection in a Patient Receiving Antiretroviral Therapy With Longstanding HIV-1 Viral Load Suppression
Author(s) -
Filipa Ceia,
André SilvaPinto,
Ana Cláudia Carvalho,
Carmela Piñeiro,
Joaquim Soares,
Rosário Serrão,
António Sarmento
Publication year - 2019
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofz063
Subject(s) - superinfection , medicine , viral load , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , sida , virus , immunology , drug resistance , lentivirus , viral disease , biology , microbiology and biotechnology
Dual human immunodeficiency virus (HIV) 1 and HIV-2 superinfections are rare but challenging. A HIV-1-infected patient receiving effective antiretroviral therapy was investigated for a severe CD4 cell count decline. HIV-2 superinfection was diagnosed and genotypic test revealed mutations conferring resistance to most drug class, limiting options for treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom